Artículo
Effectiveness of aprepitant in post-acute COVID19 syndrome
Autor/es | Reinoso Arija, Rocío
López Ramírez, Cecilia Jiménez Ruiz, José Antonio López-Campos Bodineau, José Luis ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Departamento | Universidad de Sevilla. Departamento de Medicina |
Fecha de publicación | 2021-09-18 |
Fecha de depósito | 2022-10-10 |
Publicado en |
|
Resumen | This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome |
Cita | Reinoso Arija, R., López Ramírez, C., Jiménez Ruiz, J.A. y López-Campos Bodineau, J.L. (2021). Effectiveness of aprepitant in post-acute COVID19 syndrome. Clinical Case Reports, 9 (9), 4220. https://doi.org/10.1002/ccr3.4646. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
Effectiveness of aprepitant in ... | 152.3Kb | ![]() | Ver/ | |